[Objective]To investigates the pathogenesis and clinical management of airway remodeling in chronic obstructive pulmonary disease(COPD)through the lens of mitochondrial functionality,based on the theoretical framework of"Xuanfu".[Methods]Through review of modern literature and classical Chinese medical ancient books it explores the link between mitochondrial dysfunction and COPD airway remodeling,examines how the"Xuanfu"theory relates to mitochondrial function in both physiological and pathological contexts,discusses the traditional Chinese medical(TCM)pathogenesis of COPD airway remodeling,summarizes treatment principles,and highlights contemporary studies supporting the role of TCM in modulating mitochondrial function.[Results]Mitochondrial dysfunction is crucial in COPD airway remodeling,with mechanisms and clinical manifestations aligning with"Xuanfu obstruction"and"lung collateral damage"in TCM.Based on the"Xuanfu"theory,the core pathogenesis can be described as"Xuanfu obstruction,lung collateral damage".The treatment should focus on utilizing pungent agents to disperse and ventilate,regulating Qi to open Xuanfu portals,expelling phlegm and resolving static blood,alleviating depression to free collateral vessels,reinforcing healthy Qi while eliminating pathogenic factors,strategically harmonizing unblocking with tonifying interventions.Contemporary studies indicate that intervention with traditional Chinese herbal formulas may repair pulmonary tissue damage and inhibit airway remodeling.These effects are mediated through mechanisms including the enhancement of mitochondrial energy metabolism and the promotion of mitophagy and mitochondrial biogenesis.These findings provide a modern scientific basis for the traditional pathogenesis of"Xuanfu obstruction,lung collateral damage"and its corresponding therapeutic principles in TCM.[Conclusion]The thesis propose mitochondrial dysfunction as the key pathophysiological link between the TCM mechanism of"Xuanfu obstruction,lung collateral damage"and airway remodeling in COPD.This framework establishes mitochondrial homeostasis as a core therapeutic target for TCM interventions,offering a novel basis for integrating traditional theory with modern cellular mechanisms in COPD diagnosis and treatment.

[Objective]To investigates the pathogenesis and clinical management of airway remodeling in chronic obstructive pulmonary disease(COPD)through the lens of mitochondrial functionality,based on the theoretical framework of"Xuanfu".[Methods]Through review of modern literature and classical Chinese medical ancient books it explores the link between mitochondrial dysfunction and COPD airway remodeling,examines how the"Xuanfu"theory relates to mitochondrial function in both physiological and pathological contexts,discusses the traditional Chinese medical(TCM)pathogenesis of COPD airway remodeling,summarizes treatment principles,and highlights contemporary studies supporting the role of TCM in modulating mitochondrial function.[Results]Mitochondrial dysfunction is crucial in COPD airway remodeling,with mechanisms and clinical manifestations aligning with"Xuanfu obstruction"and"lung collateral damage"in TCM.Based on the"Xuanfu"theory,the core pathogenesis can be described as"Xuanfu obstruction,lung collateral damage".The treatment should focus on utilizing pungent agents to disperse and ventilate,regulating Qi to open Xuanfu portals,expelling phlegm and resolving static blood,alleviating depression to free collateral vessels,reinforcing healthy Qi while eliminating pathogenic factors,strategically harmonizing unblocking with tonifying interventions.Contemporary studies indicate that intervention with traditional Chinese herbal formulas may repair pulmonary tissue damage and inhibit airway remodeling.These effects are mediated through mechanisms including the enhancement of mitochondrial energy metabolism and the promotion of mitophagy and mitochondrial biogenesis.These findings provide a modern scientific basis for the traditional pathogenesis of"Xuanfu obstruction,lung collateral damage"and its corresponding therapeutic principles in TCM.[Conclusion]The thesis propose mitochondrial dysfunction as the key pathophysiological link between the TCM mechanism of"Xuanfu obstruction,lung collateral damage"and airway remodeling in COPD.This framework establishes mitochondrial homeostasis as a core therapeutic target for TCM interventions,offering a novel basis for integrating traditional theory with modern cellular mechanisms in COPD diagnosis and treatment.

Objective:To establish an HPLC fingerprint of Shenling Baizhu Powder and Shenling Baizhu Pills; To evaluate the quality consistency of commercial Shenling Baizhu Powder and Shenling Baizhu Pills.Methods:HPLC method was adopted with Agilent TC-C18 column (250 mm×4.6 mm, 5 μm). The mobile phase was 0.05% phosphoric acid-acetonitrile with gradient elution; the flow rate was 1.0 ml/min; the detection wavelength was 203 nm; the column temperature was 25 ℃. The HPLC fingerprints of Shenling Baizhu Powder and Shenling Baizhu Pills from different manufacturing enterprises were established and analyzed by using the Similarity Evaluation System of Chromatographic Fingerprint of TCM (Version 2012) software for similarity evaluation, and the main chromatographic peaks were identified.Results:The control fingerprints of Shenling Baizhu Powder and Shenling Baizhu Pills were obtained. 73 common peaks and 79 common peaks were identified respectively. The similar degrees of all samples were over 0.92. The quality consistency of drugs different batches of different production enterprises was good. A total of 10 components were identified, including Liquiritin, Ginsenoside Rg1, Ginsenoside Rb1, Glycyrrhizin, Isoliquiritin, Ginsenoside Rd, Glycyrrhizic acid, AtractylenolideⅠ, AtractylenolideⅡ and AtractylenolideⅢ.Conclusions:The established HPLC fingerprints can quickly evaluate the formulation quality of Shenling Baizhu Powder and Shenling Baizhu Pills, providing basis the quality control.